News
In April 2025, the EU announced details about the first two medicinal products to undergo joint clinical assessments (JCAs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback